FDA Okays Levothyroxine Test It Objected To In Synthroid Promos - Knoll

FDA contradicted itself in accepting the Berg-Mayor method of assessing bioavailability of levothyroxine products, Knoll declared in Aug. 2 comments on FDA's levothyroxine bioavailability study guidance.